News ALK-Abelló A/S

Equities

ALK B

DK0061802139

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 28/06/2024 BST			5-day change	1st Jan Change
153.1 ^DKK	+0.99%		+5.51%	+51.28%

06-21	ALK-Abelló A/S Updates Revenue Guidance for the Year 2024	CI
06-21	ALK Provides Update on Regulatory Process for the House dust Mite Allergy Tablet in China	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ALK upgrades its full-year revenue and earnings outlook	06-21	GL
ALK-Abelló A/S Updates Revenue Guidance for the Year 2024	06-21	CI
ALK provides update on regulatory process for the house dust mite allergy tablet in China	06-21	GL
ALK Provides Update on Regulatory Process for the House dust Mite Allergy Tablet in China	06-21	CI
Transcript : ALK-Abelló A/S - Analyst/Investor Day	06-04
ALK launches new growth strategy and 2028 financial ambitions	06-03	GL
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies	06-03	GL
ALK Presents Positive Phase 3 Paediatric Trial Data Offering New Hope for Children with Respiratory Allergy	06-03	CI
ALK Abelló A/S : European registration application for ITULAZAX® for paediatric indication accepted for review	05-30	PU
ALK’s European registration application for ITULAZAX® for paediatric indication accepted for review	05-30	GL
Alk's European Registration Application for Itulazax for Pneumiatric Indication Accepted for Review	05-30	CI
ALK Abelló A/S : Listen in on ALK's Capital Markets Day on 4 June 2024	05-29	PU
Listen in on ALK’s Capital Markets Day on 4 June 2024	05-29	GL
Transcript : ALK-Abelló A/S, Q1 2024 Earnings Call, May 03, 2024	05-03
ALK Abelló A/S : Three-month interim report (Q1) 2024 (unaudited)	05-02	PU
Three-month interim report (Q1) 2024 (unaudited)	05-02	GL
ALK-Abelló A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
ALK upgrades its full-year revenue outlook	05-02	GL
ALK-Abelló A/S Updates Revenue Guidance for the Year 2024	05-02	CI
ALK-Abelló A/S Provides Earnings Guidance for the Year 2024	05-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALK-Abelló A/S : No allergy on the horizon

March 12, 2024 at 02:20 pm